These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2462502)

  • 1. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells.
    Alés-Martínez JE; Alvarez-Mon M; Merino F; Bonilla F; Martínez C; Durántez A; De la Hera A
    Eur J Immunol; 1988 Nov; 18(11):1827-30. PubMed ID: 2462502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
    Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
    J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.
    Faure F; Jitsukawa S; Meuer S; Bohuon C; Triebel F; Hercend T
    J Immunol; 1988 Apr; 140(7):2128-32. PubMed ID: 2895149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
    Samstag Y; Bader A; Meuer SC
    J Immunol; 1991 Aug; 147(3):788-94. PubMed ID: 1677669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
    Anderson P; Caligiuri M; Ritz J; Schlossman SF
    Nature; 1989 Sep; 341(6238):159-62. PubMed ID: 2528695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
    Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL
    J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.
    Hafler DA; Chofflon M; Benjamin D; Dang NH; Breitmeyer J
    J Immunol; 1989 Apr; 142(8):2590-6. PubMed ID: 2564857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD2 and CD3 antigens mobilize Ca2+ independently.
    O'Flynn K; Knott LJ; Russul-Saib M; Abdul-Gaffar R; Morgan G; Beverley PC; Linch DC
    Eur J Immunol; 1986 May; 16(5):580-4. PubMed ID: 3084290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
    Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
    Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2 can mediate TCR/CD3-independent T cell activation.
    Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
    J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.